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A B S T R A C T
The aim of this investigation was to determine the effect of exercise training on the levels of plasma cytokines and
acute phase reactants in the early post acute myocardial infarction (AMI) period. Sixty patients were enrolled into this
three-week cardiac rehabilitation study. The mean time from AMI was 7.081.60 days, and the patient mean age was
6010 years. Subjects were randomly assigned to one of the two groups: the control group treated with standard mea-
sures, and the group with additional regular moderate-intensity exercise training. Physical activity was based on the
ergospirometry test results. Apart from clinical follow-up and routine laboratory analysis we determined the levels of
plasma cytokines: tumor necrosis factor (TNF-), soluble TNF- receptor 1(TNF-SR1), interleukin (IL)-8, IL-10, and
acute phase reactants: high sensitivity C-reactive protein (hsCRP) and fibrinogen. The obtained results confirmed the hy-
pothesis that the early post AMI period is an inflammatory state the intensity of which gradually decreases with stan-
dard treatment during the first month after AMI, while including patients into early exercise training improves their in-
flammatory profile by decreasing the level of acute phase reactant and TNF-SR1.
Key words: early cardiac rehabilitation, cytokine, acute phase reactants
Introduction
Cardiovascular diseases (CVD) are the leading cause
of mortality and one of the greatest health problems in
the developing countries. Investigating mechanisms of
their origin and the possibilities of improving existing
healthcare are therefore of particular importance. In
spite of the established significance of the degree of coro-
nary obstruction1 and great expectations regarding the
investigation of endothelial dysfunction2, the existing
scientific data demonstrate that inflammation is one of
the crucial factors of occurrence and clinical course of
most CVD. It is actively involved in all levels of athe-
rogenesis, and so today atherosclerosis is recognized as a
low grade inflammatory vascular disease1. In a series of
therapeutic possibilities affecting the inflammatory com-
ponent of atherosclerotic disease, exercise training is the
most outstanding. The success of regular exercise in re-
ducing the risk of coronary disease development and
complications was convincingly associated with the re-
duction of C-reactive protein (CRP) and fibrinogen3 lev-
els, while on a sample of 28 263 healthy postmenopausal
women a prospective study of Ridker et al. has demon-
strated the predictive values of CRP and interlukin-6
(IL-6) on the development of cardiovascular events4.
Some results have shown a relation between increased
CRP and soluble tumor necrosis factor- (TNF-) values
with increased risk of coronary disease in both gen-
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ders5,6. The inverse correlation of the cardiorespiratory
exercise level with CRP values reported in a study of
Church et al. is an interesting observation, especially
considering the fact that precisely CRP is defined as a
significant predictor of the development of myocardial
reinfarction7,8. In patients with congestive heart failure
(CHF), proinflammatory cytokines TNF, soluble TNF-
receptor 1 (TNFSR1), IL-6 and CRP are significantly el-
evated, and their profile improves with regular physical
activity9,10. The positive influence of exercise training on
the reduction of IL-6 and TNFSR1 is demonstrated in a
group of patients with moderately severe and severe
CHF and ischemic heart disease9. The IL-8 is also an
atherogenic factor, a potent chemoatractant that may be
responsible for the recruitment of inflammatory cells
into the subendothelial space, adhesion of monocyte, the
migration of vascular smooth muscle cells and the pro-
motion of metalloproteinase expression. According to the
IL-8 therapeutic responses, there is a paucity of data on
the effects of regular physical training. The anti-inflam-
matory cytokine IL-10 primarily inhibits the release of
TNF-. Exercise induces a cascade of cytokine inhibitors,
but also the protective role of IL-1010.
Although the time of early rehabilitation after acute
myocardial infarction (AMI) covers a period of critical
changes in the postinfarction CHF development, it is
generally very poorly investigated11. According to acces-
sible data, the positive effects of exercise training on in-
flammation have not yet been examined in the early period
after AMI during which the most important adaptive
changes with long-term effects develop.
The aim of this investigation was to determine the in-
fluence of exercise training on the levels of plasma cyto-
kines and acute phase reactants in the early post AMI pe-
riod.
Materials and Methods
Patients after AMI (n=60) were enrolled into this
randomized, multi-center study. All patients had success-
fully undergone a percutaneous coronary intervention
(PCI), approximately 6–9 days before entry into the
study. They were included in the second phase of a
three-week rehabilitation program. During a three week
follow-up there were no significant complications. All en-
rolled patients successfully completed the program.
Exclusion criteria were: uncontrolled arrhythmias,
uncontrolled hypertension (systolic blood pressure >180
mmHg or diastolic >100 mmHg), unstable post-infarc-
tion angina, acute heart failure, abnormal hemodynamic
response or ischemic changes on electrocardiogram (ECG)
during the initial incremental load of 50 W on the ergo-
spirometry test, uncontrolled metabolic diseases, signifi-
cant orthopedic limitations, significant peripheral vascular
disease, infectious states or other inflammatory diseases,
and over 80 years of age.
Patients were randomized into the exercise training
(n=30) and the control group (n=30) by flipping a coin.
The control group without active training was provided
with standard care, whereas the training group partici-
pated in regular physical training. Before starting exer-
cise training patients were ergospirometry tested with a
Meta Max 2 Cortex (Leipzig, Germany) device, the VO2
peak was established by the respiratory spectrometry
which is routine measurement for oxygen uptake in com-
pliance with the guidelines of the American Heart Asso-
ciation10. Exercise training consisted of a 45-minute aer-
obic activity on a cycle-ergometer with exercise intensity
reaching a level of heart rate 50–60 % peak oxygen up-
take (VO2peak) monitored on ergospirometry. Addition
to this training was a daily 30-minute organized program
of supervised walking on a standardized track.
All subjects had given informed consent to the inclu-
sion in the study and the research was carried out in ac-
cordance with the principles of the Declaration of Hel-
sinki.
Inflammatory markers were determined at rest on
the second and twentieth day of the rehabilitation pro-
gram. Blood samples were collected for all investigated
patients at the same time, under the same conditions, by
venipuncture without homeostasis, after a 20 minute
rest and no physical training for 24 hours before. Test
values were determined in duplicate. Cytokines mea-
sured in the study were: TNF-, TNFSR1, IL-8 and
IL-10, while from the acute phase reactants we analyzed:
high sensitivity C-reactive protein (hsCRP) and fibrino-
gen.
The commercial enzyme-linked immunosorbent assay
(ELISA) test (Amersham Biosciences, UK), was used for
the analysis of serum values of IL-8, IL-10 and TNF-, as
well as for TNF-SR1 (R&S Systems), whereas fibrino-
gen serum values were determined by an automated co-
agulation analyzer, and hsCRP by a immunoturbidime-
trical commercial method (both (Dade-Behring, USA).
Data base created by the MS Excel program was sta-
tistically analyzed on a PC using the Statistical Data
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TABLE 1
DEMOGRAPHIC AND ANTHROPOMETRIC PARAMETERS
All patients (N=60) Training group (N=30) Controls (N=30) p
Age (years) 6010 599 6110 0.376
Gender (M/F) 44/16 21/9 23/7 0.559
BMI (kg/m–2) 28.43,8 28.83,8 28.03.8 0.392
Waist / hip ratio 1.0300.059 1.0260.073 1.0340.066 0.640
Analysis Software System, Version 7.1 StatSoft, Inc.
2005. Results are shown by average values with standard
deviations or by medians with quartile ranges; for com-
paring two sets of results, we used Student’s t-test,
Wilcoxon pared test or Mann-Whitney test (where p-
value <0.05 was considered statistically significant).
Results
Patients’ demographic and anthropometric data are
listed in Table 1. There was no significant difference in
age, sex, body mass index (BMI) and waist/ hip ratio at
the start of the trial. To the end, BMI significantly de-
creased in the total sample (28.43.8 kg/m2 to 28.23.6
kg/m2, p = 0.047), but without significant changes within
the analyzed groups (in trained patients BMI changed
from 28.83.8 kg/m2 to 28.63.5 kg/m2, p = 0.120 while
in the control group 28.03.8 kg/m2 to 27.93.8 kg/m2, p
= 0.226), and without changes in the waist / hip ratio (for
total sample 1.030.06 changed to 1.020.08, p = 0.626;
for trained patients from 1.0260.07 to 1.0270.08, p =
0.975 and for controls from 1.0340.07 to 1.0220.07, p
= 0.299).
Of the total sample 43.3 % of patients had diabetes or
glucose intolerance, without significant difference in the
prevalence between the trained (40.0 %) and the control
(46.7 %, p = 0.587) group. Standard medical therapy did
not differ between studied groups, and it was not discon-
tinued during the investigation. Angiogenesis converting
enzyme inhibitor (ACE-inhibitor) was administered to
98.3 % of patients, -blockers to 91.67 %, Aspirin to 96.67
%, clopidogrel or ticlopidine to 70 %, statins to 98.33 %,
calcium-blocking agents to 23.33 %, diuretics to 20.0 %,
nitrates to 20.0 %, peroral antidiabetics to 36.67 % and
10.41 % of patients were on insulin therapy.
The initial ergospirometry test reached VO2peak val-
ues of 18.94.6 mL/kg min for the entire group (training
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TABLE 2
CHANGES IN CLINICAL-LABORATORY PARAMETARS OF CARDIOVASCULAR RISK
All patients (N=60) Training group (N=30) Controls (N=30) p
Total cholesterol (mmol/L)
Baseline 4.501.36 4.661.60 4.351.08 0.388
Week 3 3.961.06 3.951.21 3.970,90 0.919
* –0.100.16 –0.140.14 –0.070.18 0.093
P <0.001 <0.001 0.022
Triglyceride (mmol/L)
Baseline 1.650,80 1.810.98 1.490.54 0.125
Week 3 1.530,86 1.601.02 1.470.68 0.554
* –0.060,30 –0.110.27 –0.010.32 0.186
p 0.088 0.030 0.815
HDL-cholesterol (mmol/L)
Baseline 0.750.21 0.720.17 0.770.24 0.347
Week 3 0.820.31 0.840.32 0.800.30 0.640
* 0.100.36 0.170.41 0.040.30 0.169
p 0.045 0.039 0.566
LDL-cholesterol (mmol/L)
Baseline 2.980.99 2.961.03 2.990.96 0.920
Week 3 2.500.79 2.270.72 2.730.81 0.025
 * –0.140.21 –0.220.17 –0.060.22 0.003
p) <0.001 <0.001 0.038
Total cholesterol / HDL-cholesterol
Baseline 6.42.8 6.83.0 6.12.5 0.384
Week 3 5.52.3 5.52.7 5.52.0 0.952
* –0.140.26 –0.220.25 –0.060.25 0.015
p 0.009 0.046 0.069
HbA1C (%)
Baseline 6.51.3 6.71.5 6.31.1 0.190
Week 3 6.31.2 6.41.2 6.21.2 0.445
p 0.044 0.048 0.539
relative change = (week 3 value – baseline value) / baseline value
group 20.04.4, controls 17.94.6 mL/kg min, p = 0.076).
At the end of the investigation VO2peak values increased
considerably in the trained patients (23.26.0 mL/kg
min, p0.001), while there was no significant change
(18.55.3 mL/kg min, p = 0.339) in the control group.
Comparison of VO2peak values after three weeks of reha-
bilitation revealed significantly higher values in trained
patients (p = 0.002).
Changes in the clinical-laboratory parameters of car-
diovascular risk are shown in Table 2. A significant de-
crease of total-cholesterol, LDL-cholesterol, tryglyceri-
des and glycolised hemoglobin (HbA1C) values, and a
significant rise of HDL-cholesterol were found among
trained patients after three weeks of treatment, while in
the group with standard treatment only the total and
LDL-cholesterol were lower.
Changes in the circulating levels of inflammatory
markers are shown in Table 3. During the early post AMI
period, the values of fibrinogen, hsCRP and IL-8 de-
creased in both study groups and they were significantly
lower in the group of patients with regular physical
training at the end of the study. Anti-inflammatory cy-
tokine IL-10 increased significantly in the trained group,
while the change in the control group was insignificant.
The changes of TNF- serum concentration were of bor-
derline significance in the control group, with no diffe-
rence with regard to training during the study, but the
values of TNF-SR1 dropped significantly in trained pa-
tients reaching statistically significant lower values at
the final measurements.
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TABLE 3
CHANGES IN CIRCULATING LEVELS OF INFLAMMATORY MARKERS
All patients (N=60) Training group (N=30) Controls (N=30) p
Fibrinogen (g/L)
Baseline 5.71.6 5.41.7 6.01.4 0.103
Week 3 4.81.6 4.31.2 5.31.8 0.018
P <0.001 <0.001 0.017
hsCRP (mg/L)
Baseline 14.0 (6.5–5) 13.5 (5–19) 16.5 (7–25) 0.225†
Week 3 9.0 (4–15) 5.0 (3–9) 14.0 (9–17) <0.001†
P* <0.001 <0.001 0.027
IL-8 (pg/mL)
Baseline 12.1 (8.3–17.4) 11.6 (8.1–15.1) 13.3 (9.0–18.4) 0.420†
Week 3 9.3 (6.4–14.2) 7.7 (5.8–10.5) 11.4 (8.9–19.9) 0.004†
P* <0.001 <0.001 <0.001
IL-10 (pg/mL)
Baseline 3.0 (2.4–4.8) 2.9 (2.4–4.6) 3.0 (2.2–5.3) 0.842†
Week 3 3.3 (2.3–5.6) 4.0 (2.8–5.4) 3.0 (2.0–6.0) 0.139†
P* 0.080 0.018 0.710
TNF (pg/mL)
Baseline 45.9 (27.3–60.0) 50.0 (27.0–60.1) 44.9 (27.5–56.3) 0.717†
Week 3 41.3 (20.5–63.1) 49.8 (15.1–72.4) 35.9 (26.5–49.8) 0.333†
P* 0.491 0.845 0.044
TNFSR1 (pg/mL)
Baseline 1470 (1277–1882) 1403 (1287–1751) 1553 (1267–2174) 0.420†
Week 3 1319 (1140–1715) 1231 (1030–1475) 1579 (1251–2028) 0.004†
P* <0.001 <0.001 0.361
*Wilcoxon pared test, † Mann-Whitney test
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Fig. 1. Relative hsCRP changes in different body mass index (BMI)
category.
At the beginning, the decrease of hsCRP values in the
study revealed a reverse correlation with the patient
BMI. The decrease of hsCRP for the normal (BMI 25
kg/m2), overweight (BMI 24–30 kg/m2) and obese (30
kg/m2) weight groups is presented graphically (Figure 1).
In accordance with the study design, its focus on the first
3 postinfarction weeks and the absence of significant
anthropometric value changes in analyzed patients groups,
we found no correlation of these parameters with the in-
flammatory markers, hsCRP included.
Discussion
We demonstrated in our study that the early period of
reaching clinical stability after AMI is marked by a gen-
eralized inflammatory reaction. Passive recovery and
continued medical treatment during the following three
weeks led to slow inflammatory regression, while physi-
cal training of moderate intensity had an additional
anti-inflammatory effect. Considering the study design,
we excluded the unstable and high-risk patients and es-
tablished that the applied training protocol is safe and ef-
fective in the early period of uncomplicated AMI. Beside
the inflammatory markers, active rehabilitation trig-
gered a significant improvement of the metabolic risk
profile.
The VO2 peak was defined as the best single predictor
of cardiac and total mortality in patients with known
CVD, and is considered one of the best indicators of
survival11. Early rehabilitation after AMI is inadequately
researched12. Most studies investigating the effects of
regular physical training on cardiovascular capacity and
the inflammatory status of cardiovascular patients are
based on modalities of chronic stable coronary disease.
Regular exercise training of 40–90 % VO2peak inten-
sity is recommended to patients with coronary disea-
se13–15, although such training programs are performed
at lower values in that range16. The starting VO2peak in
our research corresponds to values registered during
early cardiac rehabilitation17–19. However, the VO2peak
increase of 16 % recorded during early post-infarction
training of moderate intensity corresponds more to the
high-intensity (18 %) training results16–18 than to a mod-
erate-intensity regime (8 %) in late cardiac rehabilita-
tion15. These data could suggest significantly higher car-
diorespiratory effects of the same training protocol in the
early post-infarction phase than if applied later.
Serum hsCRP values increase after AMI as a conse-
quence of tissue lesions. Their levels are slightly in-
creased immediately after myocardial infarction; they re-
double after 8 hours, reach maximal levels on the second
to fourth day, and return to normal 3–4 weeks after
AMI20. In our study, changes in hsCRP concentration
clearly correlate with exercise training and the degree of
BMI. Since the anthropometric parameters of the sub-
jects have not changed significantly during the three
weeks of investigation, registered changes of hsCRP can-
not be attributed to the decreased body weight. The cor-
relation between hsCRP regression and weight loss is the
major limitation of all investigations with exercise train-
ing of longer duration, because it leaves an open possibi-
lity for their association and relativizes the direct anti-
-inflammatory effect of physical activity. Considering the
great public health and clinical importance of obesity21,
our study introduces an interesting observation: hsCRP
decrease inversely correlates with BMI. Since adipose tis-
sue is the source of IL-6, which is the precursor of CRP,
we presume that exercise training could directly affect
the fatty cells metabolism and cause suppression of the
inflammatory pathway. Although additional research is
required, these data suggest that overweight and obese
patients, who for their inclination towards the metabolic
syndrome represent a high-risk group in secondary car-
diovascular prevention, would particularly benefit from
early rehabilitation after AMI.
A number of studies investigated the effect of physical
activity on specific inflammatory markers. Thus, in pa-
tients with CHF a 12-week aerobic training reduces
TNF- concentration22, 6-week bicycle ergometry train-
ing reduces the concentration of TNF-SR223, and a
16-week combined aerobic/endurance training reduces
the values of both TNF soluble receptors, but not of
TNF-. In our investigation of post infarction TNF- and
TNF-SR1 dynamics we recorded a decrease of only
TNF-SR1 values in the trained group. The absence of
TNF- change supports the earlier reports on the lower
sensitivity of its serum concentration in relation to
TNF-SR122–25 suggesting that a greater sample size is
required to reliably evaluate the influence of an interven-
tion on TNF- concentration than for TNF-SR1. In the
study, we measured only the immunoactivity of the free
trimeric TNF- molecule. It is therefore also possible
that a non significant reduction in TNF- is linked to the
significant reduction of its soluble receptor in the trained
group, while in the control group the significantly lower
value of TNF- is defined by the absence of its soluble re-
ceptor decrease.
Effects of regular training on IL-10 levels are poorly
investigated. A study by Smith et al. reported an increase
of IL-10 by 36 % in subjects with high risk of developing
CVD during a 6-month exercise training26. In our study, a
similar increase of IL-10 was associated with exercise
training of post-myocardial patients in a significantly
shorter period. The initial values of inflammatory mark-
ers in our study are higher then those in other studies of
secondary cardiovascular prevention26,27, possibly becau-
se they include patients with stable coronary disease.
The significant role of IL-8 in stimulating atheroscle-
rosis is well documented28 and considered one of the lead-
ing generators of increased cardiovascular risk in dia-
betic and obese subjects29,30. Our study has shown that
IL-8 plasma concentration in the control and training
group decreased significantly but the decrease is more
obvious in trained patients. Comparing our results with
the study of Niessner A. et al., it becomes evident that
training decreased circulating IL-8, which may to some
extent explain its beneficial effect on coronary risk.31.
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The Framingham study established fibrinogen a car-
diovascular risk factor of equal significance as elevated
blood pressure, obesity, smoking and diabetes32, stressing
the fact that extended physical activity correlates with
the decrease of fibrinogen levels and with the increase of
fibrinolytic capacity33,34. Our study demonstrated the de-
crease of fibrinogen with exercise training in the early
period after AMI, for which there are no elaborated data.
Data presented in this study pointing out the possible
positive effects of early postinfarction physical training
are new reference points for further investigation of the
cardiovascular diseases associated with low intensity in-
flammations, first of all atherosclerotic CVD that are of
great importance for public health32. The obtained re-
sults confirmed the hypothesis that the early post AMI
period is an inflammatory state the intensity of which
gradually decreases with standard treatment during the
first month after AMI, while including patients into early
exercise training improves their inflammatory profile by
decreasing the level of acute phase reactant and TNF-
SR1.
According to the results of cardiorespiratory improve-
ment and anti-inflammatory potentials, the modality of
early exercise training after AMI that we have tested is a
safe and effective procedure that may possibly become a
routine modality in current cardiological practice. How-
ever, long-term effects, especially those on post-infarc-
tion myocardial remodeling, require further verification
and assessment.
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PROTUUPALNI U^INCI FIZI^KOG TRENINGA U RANOM RAZDOBLJU NAKON
AKUTNOG INFARKTA MIOKARDA
S A @ E T A K
Cilj ovog rada je bio odrediti utjecaj fizi~kog treninga na vrijednosti plazmatskih citokina i rektanata akutne faze
upale u ranom razdoblju nakon akutnog infarkta miokarda (AIM). U trotjednu studiju bolni~ke kardiolo{ke rehabili-
tacije bilo je uklju~eno 60 pacijenata. Prosje~no vrijeme od AIM je iznosilo 7,081,60 dana. Bolesnici dobi 6010 godina
bili su randomizirani u dvije skupine: kontrolnu koja je imala na raspolaganju standardne mjere lije~enja i u skupinu s
dodatnim redovitim fizi~kim treningom srednjeg intenziteta. Fizi~ka aktivnost dozirana je prema nalazu ergospirome-
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trijskog testa. Pored klini~kog pra}enja i rutinskih laboratorijskih nalaza, odre|ivane su razine plazmatskih citokina:
tumor nekrotiziraju}eg faktora  (TNF-), topivog TNF- receptora 1 (TNF-SR1), interleukina 8 (IL-8), IL-10 i reak-
tanata akutne faze: visokoosjetljivog C-reaktivnog proteina (hsCRP) i fibrinogena. Dobiveni rezultati potvr|uju pret-
postavku da upalno stanje u ranom razdoblju nakon AIM postupno regredira uz standardne mjere lije~enja tijekom
prvog mjeseca pra}enja, dok uklju~enje u rani fizi~ki trening dodatno pobolj{ava upalni status poticanjem zna~ajnijeg
pada reaktanata akutne faze upale i TNF-SR1.
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